Stephanie Meadows Shropshire

New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans

M. Bouvier, Lester Hui, C. Frost, 2022, Platelets.

Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer.

Yan Zhang, J. Penrod, L. Lal, 2023, Future oncology.

Nivolumab monotherapy or combination with ipilimumab with or without cobimetinib in previously treated patients with pancreatic adenocarcinoma (CheckMate 032)

M. Callahan, M. Tschaika, Stephanie Meadows Shropshire, 2024, Journal for ImmunoTherapy of Cancer.